# Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer

> **NCT01523457** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 75 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Folfirinox

## Key facts

- **NCT ID:** NCT01523457
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523457, "Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01523457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*